Immediate Impact

4 from Science/Nature 55 hit
Sub-graph 1 of 23

Citing Papers

Transient loss of Polycomb components induces an epigenetic cancer fate
2024 HitNature
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Hit
4 intermediate papers

Works of Robert L. Ruxer being referenced

Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy
2012

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert L. Ruxer 178 161 129 30 27 13 351
Abdel‐Ghani Azzouqa 147 0.8× 98 0.6× 118 0.9× 43 1.4× 21 0.8× 12 301
Comis Rl 190 1.1× 154 1.0× 60 0.5× 15 0.5× 34 1.3× 11 340
Gonzalo Gomez-Abuin 180 1.0× 93 0.6× 83 0.6× 26 0.9× 21 0.8× 10 347
Lorenz Jost 142 0.8× 79 0.5× 102 0.8× 28 0.9× 17 0.6× 11 342
Jie‐Hua He 214 1.2× 199 1.2× 83 0.6× 47 1.6× 21 0.8× 11 390
Martha H. Marshall 237 1.3× 208 1.3× 39 0.3× 44 1.5× 20 0.7× 10 391
Brian M.J. Cantwell 236 1.3× 127 0.8× 83 0.6× 51 1.7× 39 1.4× 21 370
Tae‐You Kim 193 1.1× 180 1.1× 120 0.9× 80 2.7× 32 1.2× 10 396
Albert Clarysse 91 0.5× 82 0.5× 95 0.7× 17 0.6× 15 0.6× 17 310
Ali Noroozi‐Aghideh 200 1.1× 127 0.8× 74 0.6× 43 1.4× 13 0.5× 14 403

All Works

Loading papers...

Rankless by CCL
2026